Companies / BOC Sciences / Emibetuzumab
BOC Sciences

Emibetuzumab | BOC Sciences

Emibetuzumab is a humanized monoclonal antibody targeting HGFR. Emibetuzumab induces internalization and degradation of MET, inhibiting proliferation of tumor cells with MET amplification and providing antitumor activity in xenograft models of NSCLC.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More